Positive effect of the ppar-gamma agonist rosiglitazone on hemodynamic response to exercise in type 2 diabetic men after coronary artery bypass graft surgery: a 1-yr randomized study
Canadian Journal of Cardiology(2016)
Abstract
To assess the effects of a 1-yr treatment with the PPAR-agonist rosiglitazone on the hemodynamic response to exercise in post-coronary artery bypass graft (CABG) surgery male patients with type 2 diabetes (T2D).
MoreTranslated text
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined